Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Preview

Cluster news

Grafische Darstellung eines Bakteriums, daneben ein Krankenbett mit einer Person, die daneben steht

Chronic Inflammatory Bowel Diseases: Does Evolutionary Medicine Offer New Therapeutic Approaches?

New experimental studies by numerous research groups, including the Max Planck Institute for Evolutionary Biology (MPI-EB) in Plön and Kiel University (CAU), suggest that evolutionary medicine could shape the future of gastroenterology. It paves the way for new approaches to treating inflammatory diseases, such as chronic inflammatory bowel diseases (IBD).

 
[EN]

New Research Training Group investigates changes in membrane proteins

German Research Foundation funds doctoral program at the CAU that links basic biochemical research with processes of disease development.

 
[EN]

Six PMI cluster members are “Highly Cited Researchers” 2024

Six members of the Cluster of Excellence “Precision Medicine in Chronic Inflammation” are among the most frequently cited researchers worldwide in 2024.

 
Plate with chips, white bread and burger buns

Irritable bowel syndrome: Using genes to predict whether a diet change can help

Genetic defects in the breakdown of carbohydrates influence the extent to which people with IBS benefit from a change in diet, study shows.